Safety and Immunogenicity of Heterologous Prime-boost With the Candidate Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP in Healthy Adults and Children in a Malaria Endemic Area.
Phase of Trial: Phase I
Latest Information Update: 13 Mar 2013
At a glance
- Drugs ME-TRAP malaria DNA vaccine Okairos (Primary) ; Rabies vaccine
- Indications Malaria; Rabies
- Focus Adverse reactions; Pharmacodynamics
- 13 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Oct 2012 Additional lead trial center identified as reported by ClinicalTrials.gov.
- 26 Sep 2012 Planned End Date changed from 1 Feb 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov record.